GlobeVerge
Home / business
MARKETS
Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
Eli Lilly now expects 2026 revenue to come in between $85 billion and $87 billion, up from a previous guidance of $82 billion and $85 billion.
GlobeSignal
Market Mover
Market-moving news like this can affect investment values and business planning.
Expand ▾
More in Finance
- IIM Kozhikode launches Bloomberg Finance Lab to strengthen graduates’ financial skills and industry readiness
- MLB trade deadline awards: The team that got better but still upset fans, the risk-takers and more
- Did Yankees do enough at trade deadline? And where does their season go from here?
- BOJ board split over JGB buying at June meeting
GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.